<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An 80-year-old man presented with multiple erythematous papules on the trunk and extremities of a few weeks' duration </plain></SENT>
<SENT sid="1" pm="."><plain>He had no past medical or family history of <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">skin diseases</z:e> or any other medical diseases </plain></SENT>
<SENT sid="2" pm="."><plain>A biopsy showed a perivascular lymphohistiocytic infiltrate and sparse neutrophils with several atypical lymphocytes in the deeper dermis </plain></SENT>
<SENT sid="3" pm="."><plain>With an initial diagnosis of T-cell <z:e sem="disease" ids="C0221269" disease_type="Disease or Syndrome" abbrv="">pseudolymphoma</z:e> or unspecified <z:e sem="disease" ids="C1142272" disease_type="Disease or Syndrome" abbrv="">neutrophilic dermatosis</z:e>, he showed a brisk response to an intramuscular injection of triamcinolone acetonide (40 mg/mL) </plain></SENT>
<SENT sid="4" pm="."><plain>After 1 month, his skin lesion recurred </plain></SENT>
<SENT sid="5" pm="."><plain>Steroid was given with a good clinical response </plain></SENT>
<SENT sid="6" pm="."><plain>One month later, however, his skin lesion relapsed </plain></SENT>
<SENT sid="7" pm="."><plain>At this time, he presented with disseminated pustulopapular lesions on the trunk and extremities </plain></SENT>
<SENT sid="8" pm="."><plain>Examination revealed multiple, variable-sized, erythematous plaques with central <z:mpath ids='MPATH_691'>pustules</z:mpath> on the extremities (Fig. 1) </plain></SENT>
<SENT sid="9" pm="."><plain>The mucous membranes were not involved </plain></SENT>
<SENT sid="10" pm="."><plain>He had no pain or tenderness </plain></SENT>
<SENT sid="11" pm="."><plain>He had no systemic symptoms </plain></SENT>
<SENT sid="12" pm="."><plain>Laboratory tests showed a <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> level of 10.3 g/dL, a leukocyte level of 6,900/mm(3), with an increased proportion of segmented nuclear neutrophils (83%), and an elevated C-reactive protein </plain></SENT>
<SENT sid="13" pm="."><plain>A skin biopsy revealed a dense perivascular and interstitial infiltrate composed of neutrophils with marked dermal <z:hpo ids='HP_0000969'>edema</z:hpo> (Fig. 2) </plain></SENT>
<SENT sid="14" pm="."><plain><z:e sem="disease" ids="C0085077" disease_type="Disease or Syndrome" abbrv="">Sweet's syndrome</z:e> was the final diagnosis and he was treated with oral <z:chebi fb="2" ids="8378">prednisolone</z:chebi> (30-40 mg/day) and dapsone (50 mg/day) for 2 months </plain></SENT>
<SENT sid="15" pm="."><plain>As this 80-year-old patient had a recurrent history of similar <z:mp ids='MP_0001212'>skin lesions</z:mp> and <z:hpo ids='HP_0001903'>anemia</z:hpo>, an underlying <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancy</z:e> was suspected </plain></SENT>
<SENT sid="16" pm="."><plain>A bone marrow biopsy showed typical <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="17" pm="."><plain>The <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> level was decreased to 5.3 g/dL during a follow-up period of 5 months </plain></SENT>
<SENT sid="18" pm="."><plain>The <z:mp ids='MP_0001212'>skin lesions</z:mp> recurred despite oral steroids and dapsone </plain></SENT>
<SENT sid="19" pm="."><plain>The patient received only symptomatic treatment, such as a transfusion, for the underlying <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>